0690.HK - Uni-Bio Science Group Limited

HKSE - HKSE Delayed Price. Currency in HKD
0.096
-0.003 (-3.03%)
As of 1:40PM HKT. Market open.
Stock chart is not supported by your current browser
Previous Close0.099
Open0.095
Bid0.095 x 0
Ask0.096 x 0
Day's Range0.095 - 0.096
52 Week Range0.093 - 0.203
Volume920,000
Avg. Volume4,100,945
Market Cap593.277M
Beta0.36
PE Ratio (TTM)N/A
EPS (TTM)-0.012
Earnings DateN/A
Forward Dividend & YieldN/A (N/A)
Ex-Dividend Date2007-08-22
1y Target EstN/A
  • Reuters3 months ago

    BRIEF-Uni-Bio Science Group Announces Strategic Cooperation Agreement With Beijing Baiao Pharmaceutical

    June 5 (Reuters) - Uni-Bio Science Group Ltd: * UNIT AND BEIJING BAIAO PHARMACEUTICAL CO., LTD. ENTERED STRATEGIC COOPERATION AGREEMENT * AGREEMENT REGARDING JOINT DEVELOPMENT AND PROMOTIONAL MARKETING ...

  • PR Newswire3 months ago

    Mr. Winston Xue, General Manager of Uni-Bio Science Healthcare Limited Was Interviewed by Bioon.com

    During the interview, Mr. Xue shared his insights on the unique transformation and development path of the innovative pharmaceutical enterprise based in Hong Kong, as well as updates of the latest research progress and future marketing model of the Group. The interview was published on May 24, 2018.

  • PR Newswire3 months ago

    Mr. Winston Xue, General Manager of Uni-Bio Science Healthcare Limited Was Interviewed by Bioon.com

    During the interview, Mr. Xue shared his insights on the unique transformation and development path of the innovative pharmaceutical enterprise based in Hong Kong, as well as updates of the latest research progress and future marketing model of the Group. The interview was published on May 24, 2018.

  • Who Are The Major Shareholders Of Uni-Bio Science Group Limited (HKG:690)?
    Simply Wall St.4 months ago

    Who Are The Major Shareholders Of Uni-Bio Science Group Limited (HKG:690)?

    Today, I will be analyzing Uni-Bio Science Group Limited’s (SEHK:690) recent ownership structure, an important but not-so-popular subject among individual investors. Ownership structure has been found to have an impactRead More...

  • PR Newswire5 months ago

    Uni-Bio Science Group Limited Posts Its 2017 Annual Results

    HONG KONG, March 30, 2018 /PRNewswire/ -- A leading integrated biopharmaceutical researcher, developer and manufacturer Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2017 (the "Year"). During the Year, the Group's marketed products, namely GeneTime®, GeneSoft®, Pinup® and Bokangtai have recorded satisfactory performance. Successfully transferred the distribution of GeneSoft® to China Resources Zizhu Pharmaceutical Co., Ltd., which has broadened the hospital coverage and achieved significant savings in sales and distribution expenses.

  • PR Newswire5 months ago

    Uni-Bio Science Group Limited Posts Its 2017 Annual Results

    HONG KONG, March 30, 2018 /PRNewswire/ -- A leading integrated biopharmaceutical researcher, developer and manufacturer Uni-Bio Science Group Limited ("Uni-Bio Science", together with its subsidiaries referred to as the "Group", stock code: 0690.HK), is pleased to announce its annual results for the year ended 31 December 2017 (the "Year"). During the Year, the Group's marketed products, namely GeneTime®, GeneSoft®, Pinup® and Bokangtai have recorded satisfactory performance. Successfully transferred the distribution of GeneSoft® to China Resources Zizhu Pharmaceutical Co., Ltd., which has broadened the hospital coverage and achieved significant savings in sales and distribution expenses.

  • Reuters5 months ago

    BRIEF-Uni-Bio Science Group Posts Loss For Year Of HK$279.3 Mln

    March 29 (Reuters) - Uni-Bio Science Group Ltd: * FY REVENUE HK$156.5 MILLION VERSUS HK$146.5 MILLION * FY LOSS FOR YEAR HK$279.3 MILLION VERSUS LOSS HK$55.7 MILLION Source text for Eikon: Further company ...

  • Was Uni-Bio Science Group Limited’s (SEHK:690) EPS Decline A Part Of Broader Industry Downturn?
    Simply Wall St.8 months ago

    Was Uni-Bio Science Group Limited’s (SEHK:690) EPS Decline A Part Of Broader Industry Downturn?

    For investors with a long-term horizon, assessing earnings trend over time and against industry benchmarks is more valuable than looking at a single earnings announcement in one point in time.Read More...